Examination of Skeletal and Senescence Phenotypes in Young Mice with Juvenile Onset Type 1 Diabetes
Calcified Tissue International · 2025
DOI: 10.1007/s00223-025-01401-w ↗Kurz gefasst
Fachartikel in der Zeitschrift Calcified Tissue International, 2025. Verfasst von Japneet Kaur und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology and Cell Biology, University of Arkansas for Medical Sciences, Little Rock, AR, USA. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 1, Bone and Bones, Cellular Senescence. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, National Institute of Diabetes and Digestive and Kidney Diseases.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Type 1 diabetes (T1D) and T2D are associated with skeletal fragility, contributing to increased fracture risk. Whereas decreased bone mineral density (BMD) is common in T1D, individuals with T2D tend to have normal or elevated BMD. These differences are incompletely understood but may stem from distinct mechanisms. Previously, we showed that obese male C57BL/6 mice (7-month-old) with T2D exhibit poor bone quality and accelerated osteocyte senescence with a unique senescence-associated secretory phenotype (SASP). We hypothesized that, similar to T2D, senescent osteocytes and additional senescent bone-resident cells (e.g., immune cells) accumulate in T1D. Consistent with previous studies, we studied a juvenile onset (2-month-old) T1D model, where following 8 weeks, male C57BL/6 mice with T1D displayed deteriorated bone microarchitecture, increased cortical porosity, and reduced bone strength. Unexpectedly, osteocytes, myeloid cells, T cells, and B cells in T1D mice showed no significant changes in key senescence/SAPS markers. Therefore, although T1D mice display several aspects of poor bone quality, consistent with juvenile-onset T1D in humans, senescent cells have yet to accumulate at substantial levels in bone at this young age. Future studies should include female mice and test whether senescence requires a later onset of T1D, a longer disease duration, or worse glycemic control.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Physiology and Cell Biology, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
- Clinical and Translational Science, University of Arizona, Tucson, AZ, 85721, USA.
- Kogod Center On Aging, Mayo Clinic, Rochester, MN, 55902, USA.
- Cellular and Molecular Medicine, University of Arizona, Tucson, AZ, 85721, USA.
- Division of Endocrinology, Department of Medicine, University of AZ, Tucson, AZ, 85721, USA.
- Division of Rheumatology, Department of Medicine, Arizona Arthritis Center, University of Arizona College of Medicine, Tucson, AZ, 85721, USA. jfarr@arizona.edu.
ORCID-Profile: Japneet Kaur, Hannah W Brooks, Mitchell N Froemming, Nicholas C Cusick, Janet L Funk, Joshua N Farr
Förderung
- NIDDK NIH HHS
- National Institute of Diabetes and Digestive and Kidney Diseases
Zitieren
APA
Kaur, J., Brooks, H. W., Froemming, M. N., Cusick, N. C., Funk, J. L., & Farr, J. N. (2025). Examination of Skeletal and Senescence Phenotypes in Young Mice with Juvenile Onset Type 1 Diabetes. Calcified Tissue International. https://doi.org/10.1007/s00223-025-01401-w
Vancouver
Kaur J, Brooks HW, Froemming MN, Cusick NC, Funk JL, Farr JN. Examination of Skeletal and Senescence Phenotypes in Young Mice with Juvenile Onset Type 1 Diabetes. Calcified Tissue International. 2025. doi:10.1007/s00223-025-01401-w
BibTeX
@article{Kaur2025,
author = {Kaur, Japneet and Brooks, Hannah W and Froemming, Mitchell N and Cusick, Nicholas C and Funk, Janet L and Farr, Joshua N},
title = {Examination of Skeletal and Senescence Phenotypes in Young Mice with Juvenile Onset Type 1 Diabetes},
journal = {Calcified Tissue International},
year = {2025},
doi = {10.1007/s00223-025-01401-w}
}
EUVIMED